SCHEMBL5354441

SCHEMBL5354441

C=Cc1cc(CC(Oc2ccc(C(C)(C)C)cc2)C(N)=O)ccc1NS(C)(=O)=O

nearest known ligand 0.54

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2957634 0.86 TRPV1 (0.52) TRPV1
SCHEMBL5272637 0.76 TRPV1 (0.48) TRPV1
SCHEMBL5486486 0.76 TRPV1 (0.53) TRPV1
SCHEMBL2948213 0.76 TRPV1 (0.57) TRPV1
SCHEMBL2948847 0.76 TRPV1 (0.47) TRPV1
SCHEMBL2955176 0.75 TRPV1 (0.51) TRPV1
SCHEMBL5345312 0.74 TRPV1 (0.43) TRPV1
SCHEMBL5223625 0.74 TRPV1 (0.38) TRPV1
SCHEMBL3386124 0.73 SLC7A5 (0.45) TRPV1
SCHEMBL3813819 0.73 TRPV1 (0.71) TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007120012-A1 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2007-10-25 WO disclosed